SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Madison Muller
Page 2 of 3
Health
Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro
By
Madison Muller
and
Bloomberg
Health
A ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’
By
Madison Muller
,
Naomi Kresge
, and others
Health
FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy
By
Madison Muller
and
Bloomberg
Health
Weight-loss drugs like Ozempic and Wegovy come with potentially serious side effects, study finds
By
Madison Muller
and
Bloomberg
Health
Weight-loss drugs like Ozempic and Wegovy may be risky for older people because they melt away all-important muscles, experts say
By
Madison Muller
and
Bloomberg
Health
Some weight loss pills used as alternatives to Ozempic and Wegovy contain toxic ingredients that are ‘potentially life-threatening’
By
Madison Muller
and
Bloomberg
Health
Yet another weight loss drug is now hard to get as high demand creates major shortages
By
Emma Court
,
Madison Muller
, and others
Retail
Baby formula prices just soared to an all-time high and manufacturers are blaming it on new regulations that ‘significantly’ raise their costs
By
Augusta Saraiva
,
Madison Muller
, and others
Health
Seniors and people with weakened immune systems can now get a second Omicron booster as new COVID subvariants emerge
By
Madison Muller
,
Fiona Rutherford
, and others
The whole world is watching to see if any new COVID variant comes out of China
By
Madison Muller
and
Bloomberg
Health
Every passenger from China will have to test negative to enter the U.S.
By
Madison Muller
and
Bloomberg
Health
Johnson & Johnson is paying $17.3 billion to buy a company that helps your heart pump blood
By
Madison Muller
and
Bloomberg
Health
Monkeypox may have just claimed its first victim in the U.S., Texas officials say
By
Madison Muller
and
Bloomberg
Health
Pets suspected of having monkeypox should be isolated, CDC says
By
Madison Muller
and
Bloomberg
Health
Lower-income Americans are losing access to life-saving treatments for anorexia: ‘There are just gross inequities in access to care’
By
Madison Muller
and
Bloomberg